E-ISSN 2578-7322
 

Review Article 


"Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma.

Abstract
.The metabolic disregulation of carbohydrates is the principal factor of diabetes, where high blood glucose levels persist which is the cause of diabetes complications, and that long-term control of blood glucose levels is required to avoid or lessen the damage caused by excess glucose. Monitoring blood sugar levels in individuals with diabetes mellitus is currently managed by a long-term testing. Albumin is the largest component of the plasma proteins, representing more than 80% of the total molecules and 60% of the total plasma protein concentration. It is replaced in the body approximately every 20-25 days, as there is a need of short term marker glycated albumin (GA) will be the ideal marker for an intermediate index to measure glycation Glycated albumin plays a double role in diabetes complications. In addition to being a marker for glycation, glycated albumin has been directly implicated for a role in several major complications of diabetes, including atherosclerosis, nephropathy, retinopathy and cognitive function. Levels of glycated albumin change more rapidly over time in response to changes in treatment than do levels of HbA1c. A recent survey of endocrinologists has demonstrated physician support for an intermediate index for glycemic control based on glycated albumin. With such a test available, doctors would recommend a substantial reduction in the level of self-monitoring blood glucose (SMBG) testing for their patients. The HbA1c test cannot effectively measure glycation within a three-month period, during which time diabetes complications can advance if unchecked. There is a demonstrated need for an intermediate glycatio index to monitor diabetes. A test based on glycated albumin could provide a stable monthly index of glycemic control.

Key words: Glycated Albumin, HbA1c, SMBG, Type 2 Diabetes


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Suresh Babu Kondaveeti
Articles by Anand Shaker Ivvala
Articles by Chidambaram Rangarajan varma
on Google
on Google Scholar
Article Statistics
 Viewed: 1521
Downloaded: 389
Cited: 0

REFERENCES
1. Cohen MP. Treatment of complications of diabetes with substancesreactive with the fructyosyl-lysine structure in glycated albumin. U.S.Patent No. 1994, 5,518,720.
2. Iberg N, Flückiger R. Nonenzymatic glycosylation of albumin invivo. Identification of multiple glycosylated sites. J Biol Chem1986;261:13542-5. [Pubmed]   
3. Available from: http://www.biomarkerbliti.org/articles/6?print=true.[Last accessed on 2014 Apr 13].
4. Hattori Y, Suzuki M, Hattori S, Kasai K. Vascular smooth muscle cellactivation by glycated albumin (Amadori adducts). Hypertension2002;39:22-8. [DOI via Crossref]    [Pubmed]   
5. Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, et al. Increasedserum glycated albumin level is associated with the presence andseverity of coronary artery disease in type 2 diabetic patients. Circ J2007;71:1067-73. [DOI via Crossref]    [Pubmed]   
6. Cohen MP, Ziyadeh FN, Chen S. Amadori-modified glycated serumproteins and accelerated atherosclerosis in diabetes: Pathogenicand therapeutic implications. J Lab Clin Med 2006;147:211-9. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
7. Brownlee M, Pongor S, Cerami A. Covalent attachment of solubleproteins by nonenzymatically glycosylated collagen. Role in the insitu formation of immune complexes. J Exp Med 1983;158:1739-44. [DOI via Crossref]    [Pubmed]   
8. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, ShearmanCW. Glycated albumin stimulation of PKC-beta activity is linked toincreased collagen IV in mesangial cells. Am J Physiol 1999;276:F684-90. [Pubmed]   
9. Thomas MC, Tikellis C, Burns WM, Bialkowski K, Cao Z, Coughlan MT,et al. Interactions between renin angiotensin system and advancedglycation in the kidney. J Am Soc Nephrol 2005;16:2976-84. [DOI via Crossref]    [Pubmed]   
10. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP. Glycated albuminstimulates fibronectin gene expression in glomerular mesangial cells:Involvement of the transforming growth factor-beta system. KidneyInt 1998;53:631-8. [DOI via Crossref]    [Pubmed]   
11. Bohrer MP, Deen WM, Robertson CR, Troy JL, Brenner BM. Influenceof molecular configuration on the passage of macromolecules acrossthe glomerular capillary wall. J Gen Physiol 1979;74:583-93. [DOI via Crossref]    [Pubmed]   
12. Williams SK, Siegal RK. Preferential transport of non-enzymaticallyglucosylated ferritin across the kidney glomerulus. Kidney Int1985;28:146-52. [DOI via Crossref]    [Pubmed]   
13. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G,et al. Nephrin expression is reduced in human diabetic nephropathy:Evidence for a distinct role for glycated albumin and angiotensin II.Diabetes 2003;52:1023-30. [DOI via Crossref]    [Pubmed]   
14. Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, et al.Prevention of diabetic nephropathy in db/db mice with glycatedalbumin antagonists. A novel treatment strategy. J Clin Invest1995;95:2338-45. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
15. Okumura A, Mitamura Y, Namekata K, Nakamura K, Harada C, HaradaT. Glycated albumin induces activation of activator protein-1 in retinalglial cells. Jpn J Ophthalmol 2007;51:236-7. [DOI via Crossref]    [Pubmed]   
16. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, andfructosamine and analysis of their weight functions against precedingplasma glucose level. Diabetes Care 1995;18:440-7. [DOI via Crossref]   
17. Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K,et al. Comparison of glycated albumin (GA) and glycated hemoglobin(HbA1c) in type 2 diabetic patients: Usefulness of GA for evaluationof short-term changes in glycemic control. Endocr J 2007;54:139-44. [DOI via Crossref]    [Pubmed]   
18. Koga M, Matsumoto S, Saito H, Kasayama S. Body mass indexnegatively influences glycated albumin, but not glycated hemoglobin,in diabetic patients. Endocr J 2006;53:387-91. [DOI via Crossref]    [Pubmed]   
19. Yoshida N, Okumura K, Aso Y. High serum pentosidine concentrationsare associated with increased arterial stiffness and thickness inpatients with type 2 diabetes. Metabolism 2005;54:345-50. [DOI via Crossref]    [Pubmed]   
20. Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E,et al. Performance characteristics and clinical utility of an enzymaticmethod for the measurement of glycated albumin in plasma. ClinBiochem 2007;40:1398-405. [DOI via Crossref]    [Pubmed]   
21. Jones IR, Owens DR, Williams S, Ryder RE, Birtwell AJ, Jones MK,et al. Glycosylated serum albumin: An intermediate index of diabeticcontrol. Diabetes Care 1983;6:501-3. [DOI via Crossref]    [Pubmed]   
22. Winocour PH, Bhatnagar D, Kalsi P, Hillier VF, Anderson DC. Acomparison of direct measures of glycaemia and glycated bloodproteins in insulin-dependent diabetes mellitus. Clin Biochem1989;22:457-61. [DOI via Crossref]   
23. Wörner W, Pfleiderer S, Rietbrock N. Selective determination of nonenzymaticglycosylated serum albumin as a medium term index ofdiabetic control. Int J Clin Pharmacol Ther Toxicol 1993;31:218-22. [Pubmed]   
24. Kawamori R. Insulin resistance seen in non-insulin dependentdiabetes mellitus and hypertension. Hypertens Res 1996;19 Suppl1:S61-4. [DOI via Crossref]    [Pubmed]   
25. Tamemoto H, Toyoshima H, Saitoh T, Yuzawa M, Yuzawa M,Ishikawa S, et al. Efficacy of glycoalbumin to monitor rapidly changingblood glucose. ADA 2007;Suppl 3:25-32. Abstract
26. Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus.Biochim Biophys Acta 2013;1830:5509-14. [DOI via Crossref]    [Pubmed]   
27. Koga M, Kasayama S. Clinical impact of glycated albumin as anotherglycemic control marker. Endocr J 2010;57:751-62. [DOI via Crossref]   
28. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, et al.Plasma glycated albumin level and atherosclerosis: Results fromthe Kyushu and Okinawa Population Study (KOPS). Int J Cardiol2013;167:2066-72. [DOI via Crossref]    [Pubmed]   
29. Song SO, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Serum glycatedalbumin predicts the progression of carotid arterial atherosclerosis.Atherosclerosis 2012;225:450-5. [DOI via Crossref]    [Pubmed]   
30. Available from: http://www.epinex.com/newsletter/Epinex_Newsletter4.pdf. [Last accessed on 2014 Apr 13]
31. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769832/figure/fig1/. [Last accessed on 2014 Apr 13]
32. Baker JR, O’Connor JP, Metcalf PA, Lawson MR, Johnson RN. Clinicalusefulness of estimation of serum fructosamine concentrationas a screening test for diabetes mellitus. Br Med J (Clin Res Ed)1983;287:863-7. [DOI via Crossref]   
33. Shima K, Abe F, Chikakiyo H, Ito N. The relative value of glycatedalbumin, hemoglobin A1c and fructosamine when screening fordiabetes mellitus. Diabetes Res Clin Pract 1989;7:243-50. [DOI via Crossref]   
34. Guillausseau PJ, Charles MA, Paolaggi F, Timsit J, Chanson P, Peynet J,et al. Comparison of HbA1 and fructosamine in diagnosis of glucosetoleranceabnormalities. Diabetes Care 1990;13:898-900. [DOI via Crossref]    [Pubmed]   
35. Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Inawashiro H, Fukao A,et al. Receiver operating characteristic analysis on fasting plasmaglucose, HbA1c, and fructosamine on diabetes screening. DiabetesCare 1991;14:1075-7. [DOI via Crossref]    [Pubmed]   
36. Kasezawa N, Kiyose H, Ito K, Iwatsuka T, Kawai H, Goto Y, et al.Criteria for screening diabetes mellitus using serum fructosaminelevel and fasting plasma glucose level. The Japanese Society ofMultiphasic Health Testing and Services (JMHT), FructosamineWorking Committee. Methods Inf Med 1993;32:237-40. [Pubmed]   
37. Cefalu WT, Ettinger WH, Bell-Farrow AD, Rushing JT. Serumfructosamine as a screening test for diabetes in the elderly: A pilotstudy. J Am Geriatr Soc 1993;41:1090-4. [Pubmed]   
38. Narayanan S. Laboratory monitoring of gestational diabetes. Ann ClinLab Sci 1991;21:392-401. [Pubmed]   
39. Carter AW. Home fructosamine testing: Is its demise premature?Diabetes Technol Ther 2002;4:643-4. [DOI via Crossref]    [Pubmed]   
40. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769832/figure/fig2/. [Last accessed on 2014 Apr 13]
41. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T,et al. Glycated albumin is a better glycemic indicator than glycatedhemoglobin values in hemodialysis patients with diabetes:Effect of anemia and erythropoietin injection. J Am Soc Nephrol2007;18:896-903. [DOI via Crossref]    [Pubmed]   
42. Leiper JM, Talwar D, Robb DA, Lunan CB, MacCuish AC. Glycosylatedalbumin and glycosylated proteins: Rapidly changing indices ofglycaemia in diabetic pregnancy. Q J Med 1985;55:225-31. [Pubmed]   
43. Davis WA, Bruce DG, Davis TM. Does self-monitoring of bloodglucose improve outcome in type 2 diabetes? The Fremantle DiabetesStudy. Diabetologia 2007;50:510-5. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
44. Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, et al. Is thefrequency of self-monitoring of blood glucose related to long-termmetabolic control? Multicenter analysis including 24,500 patientsfrom 191 Centers in Germany and Austria. Exp Clin EndocrinolDiabetes 2006;114:384-8. [DOI via Crossref]    [Pubmed]   
45. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D,Di Nardo B, et al. The impact of blood glucose self-monitoring onmetabolic control and quality of life in type 2 diabetic patients:An urgent need for better educational strategies. Diabetes Care2001;24:1870-7. [DOI via Crossref]    [Pubmed]   
46. Thoolen BJ, de Ridder DT, Bensing JM, Gorter KJ, Rutten GE.Psychological outcomes of patients with screen-detected type2 diabetes: The influence of time since diagnosis and treatmentintensity. Diabetes Care 2006;29:2257-62. [DOI via Crossref]    [Pubmed]   
47. Jeffcoate SL. Diabetes control and complications: The role ofglycated haemoglobin, 25 years on. Diabet Med 2004;21:657-65. [DOI via Crossref]    [Pubmed]   
48. Kasayama S, Morita S, Saito H, Mikio M, Koga M. Glycatedhemoglobin, but not serum glycated albumin, is influenced byerythrocyte and iron metabolism indices in pre-menopausal women.ADA Abstract, 2007.
49. Gould BJ, Davie SJ, Yudkin JS. Investigation of the mechanismunderlying the variability of glycated haemoglobin in non-diabeticsubjects not related to glycaemia. Clin Chim Acta 1997;260:49-64. [DOI via Crossref]   
50. Rendell M, Stephen PM, Paulsen R, Valentine JL, Rasbold K,Hestorff T, et al. An interspecies comparison of normal levels ofglycosylated hemoglobin and glycosylated albumin. Comp BiochemPhysiol B 1985;81:819-22. [DOI via Crossref]   
51. Hudson PR, Child DF, Jones H, Williams CP. Differences in rates ofglycation (glycation index) may significantly affect individual HbA1cresults in type 1 diabetes. Ann Clin Biochem 1999;36:451-9. [DOI via Crossref]    [Pubmed]   
52. Madsen H, Ditzel J. Changes in red blood cell oxygen transport indiabetic pregnancy. Am J Obstet Gynecol 1982;143:421-4. [Pubmed]   
53. Szwergold BS, Howell SK, Beisswenger PJ. Intracellular nonenzymaticglycation of hemoglobin in human erythrocytes is controlled byenzymatic deglycation mechanisms. Diabetes 2003;52 Suppl 1:A190.[Abstract #815].
54. Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobinvariants and determination of glycated hemoglobin (HbA1c). DiabetesMetab Res Rev 2001;17:94-8. [DOI via Crossref]    [Pubmed]   
55. Holmes E, Ersahin C, Augustine G, Gryzbac M, Murrell J, McKenna K,et al. Glycated albumin low in obese, type 2 diabetic patients. AACCConference Abstract; 2006.
56. Miyashita Y, Nishimura R, Morimoto A, Matsudaira T, Sano H,Tajima N. Glycated albumin is low in obese, type 2 diabetic patients.Diabetes Res Clin Pract 2007;78:51-5. [DOI via Crossref]    [Pubmed]   
57. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S.Negative association of obesity and its related chronic inflammationwith serum glycated albumin but not glycated hemoglobin levels.Clin Chim Acta 2007;378:48-52. [DOI via Crossref]    [Pubmed]   
58. Koga M, Murai J, Saito H, Matsumoto S, Kasayama S. Effects ofthyroid hormone on serum glycated albumin levels: Study on nondiabeticsubjects. Diabetes Res Clin Pract 2009;84:163-7. [DOI via Crossref]    [Pubmed]   
59. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H,et al. Influence of proteinuria on glycated albumin values in diabeticpatients with chronic kidney disease. Intern Med 2011;50:23-9. [DOI via Crossref]    [Pubmed]   
60. Times of India, Diabetes epidemic on the rise in India, 2013.Available from: http://www.timesofindia.indiatimes.com/life-style/health-fitness/health/Diabetes-epidemic-on-the-rise-in-India/articleshow/25758884.cms. [Last accessed on 2014 Apr 13]
61. Satyavani K, Priyanka T, Vishwanath V. Efficacy of glycated albumin(GA) in comparison with glycated haemoglobin (HbA1c) in type 2diabetic subject in India. JK Sci J Med Educ Res 2011;13:1-5.
62. Kondaveeti SB, DK, Mishra S, Kumar RA, Shaker IA. Evaluationof glycated albumin and microalbuminuria as early risk markersof nephropathy in type 2 diabetes mellitus. J Clin Diagn Res2013;7:1280-3. [Pubmed]    [PMC Free Fulltext]   
63. Kondaveeti SB, Kumar RA, Shaker IA. Glycated albumin andmicroalbuminuria as risk factors in diabetic retinopathy of type 2diabetis mellitus. J Biol Sci Opinion 2013;1:1-4. [DOI via Crossref]   
64. Kondaveeti SB, Shaker IA, Kumar RA, Palwan H, Raja G. Evaluationof glycated albumin and dyslipidemia in type 2 diabetes mellitus. IntJ Bioassays 2012;01:112-5.

How to Cite this Article
Pubmed Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. A J Physiol Biochem Pharmacol. 2014; 3(2): 86-92. doi:10.5455/jib.20140718044724


Web Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. http://www.ajpbp.com/?mno=159067 [Access: December 13, 2018]. doi:10.5455/jib.20140718044724


AMA (American Medical Association) Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. A J Physiol Biochem Pharmacol. 2014; 3(2): 86-92. doi:10.5455/jib.20140718044724



Vancouver/ICMJE Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. A J Physiol Biochem Pharmacol. (2014), [cited December 13, 2018]; 3(2): 86-92. doi:10.5455/jib.20140718044724



Harvard Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma (2014) "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. A J Physiol Biochem Pharmacol, 3 (2), 86-92. doi:10.5455/jib.20140718044724



Turabian Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. 2014. "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. American Journal of Physiology, Biochemistry and Pharmacology, 3 (2), 86-92. doi:10.5455/jib.20140718044724



Chicago Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. ""Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.." American Journal of Physiology, Biochemistry and Pharmacology 3 (2014), 86-92. doi:10.5455/jib.20140718044724



MLA (The Modern Language Association) Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma. ""Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.." American Journal of Physiology, Biochemistry and Pharmacology 3.2 (2014), 86-92. Print. doi:10.5455/jib.20140718044724



APA (American Psychological Association) Style

Suresh Babu Kondaveeti, Anand Shaker Ivvala, Chidambaram Rangarajan varma (2014) "Glycated Albumin" A New Paradigm In Better Monitoring Type 2 Diabetes Complications As A Short Term Glycemic Index.. American Journal of Physiology, Biochemistry and Pharmacology, 3 (2), 86-92. doi:10.5455/jib.20140718044724





Most Viewed Articles
  • Slippery Elm, its Biochemistry, and use as a Complementary and Alternative Treatment for Laryngeal Irritation
    Christopher R Watts, Bernard rousseau
    J Investig Biochem. 2012; 1(1): 17-23
    » Abstract & References » doi: 10.5455/jib.20120417052415

  • Selected disease fundamentals based on the unified cell bioenergetics
    Andrzej Kasperski, Renata Kasperska
    J Investig Biochem. 2013; 2(2): 93-100
    » Abstract & References » doi: 10.5455/jib.20130227041230

  • Prevalence of vitamin B12 deficiency in Helicobacter pylori infected patients in Jordan.
    Saad Abed Aljalil Alfawaeir, Mohammad Basim Abuzaid
    J Investig Biochem. 2013; 2(1): 21-25
    » Abstract & References » doi: 10.5455/jib.20121215061954

  • Serum levels of high-sensitivity C-reactive protein (hs-CRP) in Helicobacter pylori infected patients
    Saad Al-Fawaeir, Mohammad Basim Abu Zaid
    J Investig Biochem. 2013; 2(1): 32-36
    » Abstract & References » doi: 10.5455/jib.20121225015606

  • Molecular Characterization of Alpha and Beta Thalassemia in Yemeni Sickle Cell Disease Children
    Saeed Thabet Nasher, Mohammed Wael Abu Ghoush
    J Investig Biochem. 2013; 2(1): 44-52
    » Abstract & References » doi: 10.5455/jib.20130105022014

  • Hepatoprotective and In vivo Anti-oxidant Activity of Costus afer Leaf Extracts against Acetaminophen-Induced Hepatotoxicity in Rats
    God'swill Nduka Anyasor, Kofoworola O. Odunsanya, Audrey C. Ibeneme
    J Investig Biochem. 2013; 2(1): 53-61
    » Abstract & References » doi: 10.5455/jib.20130301030851

  • Correlation Between Elevated Hepatic Enzymes & High-Sensitivity Crp in Metabolic Syndrome.
    Al-Rubaye Faisal, Shakir Mahmood, Jumah Kadhum
    J Investig Biochem. 2012; 1(1): 6-11
    » Abstract & References » doi: 10.5455/jib.20120528094732

  • Serum Lipid Profile of Breast Cancer Patients in Kashmir
    Showkat Ahmad Bhat, Manzoor R Mir, Sabhiya Majid, Ahmad Arif Reshi, Ishraq Husain, Tehseen Hassan, Hilal Ahmad
    J Investig Biochem. 2013; 2(1): 26-31
    » Abstract & References » doi: 10.5455/jib.20121125075314

  • Alteration of antioxidant enzymes and oxidative stress in elderly patient.
    Seema L. Jawalekar1, Anil K. Bhutey2, Aarti Karnik3, Vasant T. Surve4
    J Investig Biochem. 2013; 2(1): 37-43
    » Abstract & References » doi: 10.5455/jib.20130129093838

  • Potential Role of Oxidized LDL (ox-LDL) and Adhesion Molecules (VCAM-1, ICAM-1) in Type 2 Diabetes Mellitus Patients in Qassim region, KSA
    Manal Basyouni, Maha Ahmed, Hisham Ismail , Iman Esmat
    J Investig Biochem. 2012; 1(1): 48-54
    » Abstract & References » doi: 10.5455/jib.20120417052458

  • Most Downloaded
  • Slippery Elm, its Biochemistry, and use as a Complementary and Alternative Treatment for Laryngeal Irritation
    Christopher R Watts, Bernard rousseau
    J Investig Biochem. 2012; 1(1): 17-23
    » Abstract & References » doi: 10.5455/jib.20120417052415

  • Selected disease fundamentals based on the unified cell bioenergetics
    Andrzej Kasperski, Renata Kasperska
    J Investig Biochem. 2013; 2(2): 93-100
    » Abstract & References » doi: 10.5455/jib.20130227041230

  • Serum levels of high-sensitivity C-reactive protein (hs-CRP) in Helicobacter pylori infected patients
    Saad Al-Fawaeir, Mohammad Basim Abu Zaid
    J Investig Biochem. 2013; 2(1): 32-36
    » Abstract & References » doi: 10.5455/jib.20121225015606

  • Alteration of antioxidant enzymes and oxidative stress in elderly patient.
    Seema L. Jawalekar1, Anil K. Bhutey2, Aarti Karnik3, Vasant T. Surve4
    J Investig Biochem. 2013; 2(1): 37-43
    » Abstract & References » doi: 10.5455/jib.20130129093838

  • Serum Lipid Profile of Breast Cancer Patients in Kashmir
    Showkat Ahmad Bhat, Manzoor R Mir, Sabhiya Majid, Ahmad Arif Reshi, Ishraq Husain, Tehseen Hassan, Hilal Ahmad
    J Investig Biochem. 2013; 2(1): 26-31
    » Abstract & References » doi: 10.5455/jib.20121125075314

  • Hepatoprotective and In vivo Anti-oxidant Activity of Costus afer Leaf Extracts against Acetaminophen-Induced Hepatotoxicity in Rats
    God'swill Nduka Anyasor, Kofoworola O. Odunsanya, Audrey C. Ibeneme
    J Investig Biochem. 2013; 2(1): 53-61
    » Abstract & References » doi: 10.5455/jib.20130301030851

  • Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus
    Suresh Babu Kondaveeti, Ivvala Anand Shaker
    J Investig Biochem. 2013; 2(2): 127-131
    » Abstract & References » doi: 10.5455/jib.20130507061739

  • Comparative study of ischemia modified albumin and nitric oxide in hyperthyroidism
    Monica Verma1, Kiran Dahiya1, Veena Singh Ghalaut1, Abhishek Soni2, Jagjeet Singh3, Vasudha Dhupper1
    J Investig Biochem. 2014; 3(1): 17-20
    » Abstract & References » doi: 10.5455/jib.20130707090209

  • Prevalence of vitamin B12 deficiency in Helicobacter pylori infected patients in Jordan.
    Saad Abed Aljalil Alfawaeir, Mohammad Basim Abuzaid
    J Investig Biochem. 2013; 2(1): 21-25
    » Abstract & References » doi: 10.5455/jib.20121215061954

  • Serum lipid profile in Helicobacter pylori infected patients
    Saad Al-Fawaeir, Mohammad Abu Zaid, Ayman Abu Awad, Baker Alabedallat
    J Investig Biochem. 2013; 2(2): 132-135
    » Abstract & References » doi: 10.5455/jib.20130603084538

  • Most Cited Articles
  • Biochemical study on the impact of Nigella sativa and virgin olive oils on cadmium-induced nephrotoxicity and neurotoxicity in rats
    Eman Taha Mohammed, Khalid Shaban Hashem, Mahmoud Ramadan Abdel Rheim
    J Investig Biochem. 2014; 3(2): 71-78
    » Abstract & References » doi: 10.5455/jib.20140716041908
    Cited : 6 times [Click to see citing articles]

  • Study and Characterization of the Antioxidant Activity of the Inclusion Complex of Apigenin with β-Cyclodextrin and HP-β-Cyclodextrin in solution
    Jinxia Li
    J Investig Biochem. 2014; 3(3): 107-111
    » Abstract & References » doi: 10.5455/jib.20140905032504
    Cited : 5 times [Click to see citing articles]

  • Slippery Elm, its Biochemistry, and use as a Complementary and Alternative Treatment for Laryngeal Irritation
    Christopher R Watts, Bernard rousseau
    J Investig Biochem. 2012; 1(1): 17-23
    » Abstract & References » doi: 10.5455/jib.20120417052415
    Cited : 4 times [Click to see citing articles]

  • Alterations in plasma lipids, glutathione and homocysteine in relation to dietary copper in rats
    Magda A. Megahed1, Kamel M. A. Hassanin2, Ibrahim M. I. Youssef3, Abdul Baset A. Elfghi4, Kamal A. Amin2
    J Investig Biochem. 2014; 3(1): 21-25
    » Abstract & References » doi: 10.5455/jib.20130716075753
    Cited : 4 times [Click to see citing articles]

  • Quercetin, a natural phytochemical and antioxidant protects against sodium azide-induced hepatic and splenic oxidative stress in rats
    Oluwatobi Temitope Somade, Oluseyi Adeboye Akinloye, Michael Oluwayemi Adeyeye, Gbenga Daniel Fabunmi, Olakunle Opeoluwa Idowu, Funmilayo Oluwaseun Badmus, Barakat Oluwatoyin Salaudeen
    J Investig Biochem. 2015; 4(3): 69-74
    » Abstract & References » doi: 10.5455/jib.20151220014400
    Cited : 3 times [Click to see citing articles]

  • A New Marker For The Diagnoss Of Sepsis: Presepsin
    Mehmet Agilli, Irfan Sener, Fatih Yesildal, Tevfik Honca, Ibrahim Aydin, Emin Ozgur Akgul, Halil Yaman
    J Investig Biochem. 2012; 1(1): 55-57
    » Abstract & References » doi: 10.5455/jib.20120521073837
    Cited : 3 times [Click to see citing articles]

  • The role of urinary 5- hydroxyindoleacetic acid determination in diagnosis of acute appendicitis
    Hamid Hindi Sarhan, Aseel Fawzi Hatroosh, Amina Hamed Alobaidi
    J Investig Biochem. 2013; 2(1): 1-5
    » Abstract & References » doi: 10.5455/jib.20121026084836
    Cited : 3 times [Click to see citing articles]

  • Serum Lipid Profile of Breast Cancer Patients in Kashmir
    Showkat Ahmad Bhat, Manzoor R Mir, Sabhiya Majid, Ahmad Arif Reshi, Ishraq Husain, Tehseen Hassan, Hilal Ahmad
    J Investig Biochem. 2013; 2(1): 26-31
    » Abstract & References » doi: 10.5455/jib.20121125075314
    Cited : 3 times [Click to see citing articles]

  • Phytochemical content of Cnidoscolus aconitifolius leaves and toxicological effect of its aqueous leaf extract in Wistar rats
    Doris Akachukwu, Polycarp Nnacheta Okafor, Chiedozie O Ibegbulem
    J Investig Biochem. 2014; 3(1): 26-31
    » Abstract & References » doi: 10.5455/jib.20140504023102
    Cited : 3 times [Click to see citing articles]

  • Myeloperoxidase, Malondialdehyde and serum Lipids in type 2 diabetes mellitus
    Mohamedi Begum, Ashok Kumar J., Hilda Priya D'Souza, Sushith Sushith, Prathima M.B, Reshma S., Shashikala M.D, Manjula Anil, Suriyan S Nair, Kavitha Ashok Kumar
    J Investig Biochem. 2015; 4(1): 13-17
    » Abstract & References » doi: 10.5455/jib.20150331115356
    Cited : 3 times [Click to see citing articles]